Navigation Links
Cochlear Americas Receives FDA Approval of the World's Thinnest, Full Length Electrode for Cochlear Implantation
Date:6/12/2012

CENTENNIAL, Colo., June 12, 2012 /PRNewswire/ -- Cochlear Americas announced today that the US Food & Drug Administration (FDA) has approved the Nucleus CI422 with Slim Straight Electrode, the newest electrode in its broad portfolio of implantable hearing solutions. The Slim Straight, along with other Cochlear electrodes, is uniquely designed for preservation of delicate cochlear structures, to deliver the best possible hearing performance and to accommodate specific preferences with anatomy and technique in the widest range of patient conditions.

"This approval underscores Cochlear's design philosophy, which is to take the very best of what we've learned from each generation of electrode and apply it to improve the next," said Chris Smith, President of Cochlear Americas. "The addition of the Nucleus CI422, the world's thinnest, full length electrode, to our comprehensive portfolio is a strong testament to our ongoing collaboration with surgeons and clinicians to help meet the individual needs of patients."

Cochlear continues to empower surgeons with electrodes that accommodate elements of preservation, insertion, stimulation and performance.  Within the portfolio, there are distinct categories of high performance electrodes, each with 22 active contacts, designed for insertions into scala tympani to maximize hearing performance. All Cochlear Nucleus electrodes contain a unique balance of features intended to preserve the delicate structures of the inner ear. The new Slim Straight takes this to the next level with its patented unique design combination of apical flexibility and basal support to allow for a smooth single motion insertion and minimal trauma. In addition, the electrode features a patented Softip and half banded contacts for a smooth silicone lateral wall surface.

"Different patients, surgical preferences and audiological conditions require unique solutions," said Dr. Pete Weber, Chief Medical Officer for Cochlear. "Each of Cochlear's tailored, high performance electrodes exhibits a powerful combination of individual features, state of the art materials and hearing performance capability, all designed to enable the very best outcomes in each patient - whether that be a child or adult."

About Cochlear Implants

Cochlear implants are a proven medical option for children as young as 12 months old with profound hearing loss in both ears, for children who are two years or older with severe-to-profound hearing loss in both ears who obtain little or no benefit from hearing aids, and for adults with moderate-to-profound hearing loss in both ears. They are electronic devices, typically covered by health insurance, which bypass damaged hair cells in the inner ear, or cochlea, and stimulate the hearing nerve directly.

About Cochlear

Cochlear is the world leader in advanced hearing technologies. Since launching the first multichannel cochlear implant system 30 years ago, Cochlear Limited and its U.S. headquarters have brought the miracle of sound to more than 250,000 people with hearing loss across the globe. For more information about Cochlear Americas products, please visit www.cochlearamericas.com.


'/>"/>
SOURCE Cochlear Americas
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Cochlear™ Americas Adds the Nucleus® Support App to its Mobile Service Offerings
2. Utah Boy Scout Troop Cycles 314 Miles, Raising Awareness of Cochlear Implants
3. DICOM Grid Selected as a Finalist for the 2012 Red Herring Top 100 Americas Award
4. PAREXEL Chief Operating Officer Dr. Mark A. Goldberg Receives Special Recognition Award
5. Leica Biosystems Receives FDA Approval for the Fully Automated Bond Oracle™ HER2 IHC System on the Leica BOND-MAX
6. Nephros Receives 510(k) Clearance for Hemodiafiltration System
7. ProUroCare Medical Receives FDA Clearance for ProUroScan Elasticity Imaging System
8. BONESUPPORT Receives Red Herring 2012 Top 100 Europe Award
9. Diabecline Antibiotic Receives Edison Award for Best New Pharmaceutical Product
10. Lexicon Receives Funding for Phase 2 Clinical Trial of LX4211 in Type 1 Diabetes
11. Alexza Receives Complete Response Letter for Adasuve™ NDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... Research and Markets has announced the addition ... report to their offering. ... The ablation device global market is expected to ... 2023. Ablation is the minimally invasive therapeutic tissue ... or diseased tissue removal, to the removal of abnormally conducting cardiac ...
(Date:3/29/2017)... , March 29, 2017   Dynatronics ... today the appointment of Cynthia L. McHenry ... will be responsible for leading Dynatronics manufacturing, distribution, ... will report to Dynatronics, CEO Kelvyn H. ... concludes an extensive search process conducted by the ...
(Date:3/29/2017)... 29, 2017 FinancialBuzz.com News Commentary  ... Data published in a research report by Grand ... a value of USD 55.8 billion by 2025. The projection takes into ... and a more open approach towards cannabis products around the ... Florida , North Dakota , Ohio ...
Breaking Medicine Technology:
(Date:3/29/2017)... ... March 29, 2017 , ... VisualSP has helped over 1.5 million ... only option for on-premises installation of its Help System for SharePoint was at the ... system into the entire tenant. , The company recently released a modified version ...
(Date:3/28/2017)... ... ... For many women, getting birth control isn’t as easy as it should be. In fact, ... to a health care facility or a pharmacy within 60 minutes of where they live. ... for many who are faced with health or personal issues that leave them homebound. To ...
(Date:3/28/2017)... Rochester, MN (PRWEB) , ... March 28, 2017 ... ... Elastography (MRE), is pleased to be invited to the Siemens Healthineers annual ... imaging professionals. The event will take place from March 27 - 31, ...
(Date:3/28/2017)... ... March 29, 2017 , ... Dr. Isabella Wentz, PharmD, FASCP, one of ... series titled The Thyroid Secret. Dr. Wentz talked about journey and research recently on ... that medication IS NOT the only solution to deal with thyroid disease. , ...
(Date:3/28/2017)... San Mateo, CA (PRWEB) , ... ... ... Radiosurgery Society (RSS), a non-profit medical society dedicated to advancing the science ... manuscript leveraging data from its RSSearch Patient Registry, a multi-institutional, observational registry ...
Breaking Medicine News(10 mins):